Compare
DEno tier3 verifiedremove
Claims
- Science Based Targets initiativeverified · expires 2027-08-15
- Science Based Targets initiative (net-zero)verified · expires 2027-08-20
- Science Based Targets initiative (long-term)verified · expires 2027-08-20
DEno tier1 verifiedremove
Grünenthal is a science-based, privately-owned pharmaceutical company focused on pain management and related diseases, with a long track record of bringing innovative treatments to patients worldwide. The company is committed to delivering sustainable growth and expanding its portfolio through innovation and strategic acquisitions.
Claims
- Science Based Targets initiativeverified · expires 2027-08-15